ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks Slapy, I would be surprised if they spent any money on the further development of Libigel. Pryzbyl appears to be trying to create a low cost business model, getting into cost sharing agreement for further development would greatly increase there R&D cost.

On the other hand out-licensing Libigel with future milestone & royalty payments in addition to a long term manufacturing contract would definitely fit their low cost business model.